Roche Joins Race for Obesity Drugs With $2.7 Billion Carmot Deal ...Middle East

Medscape - News
Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk and Eli Lilly. Reuters Health Information

Hence then, the article about roche joins race for obesity drugs with 2 7 billion carmot deal was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Roche Joins Race for Obesity Drugs With $2.7 Billion Carmot Deal )

Apple Storegoogle play

Last updated :

Also on site :